Blaze Bioscience Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Blaze Bioscience Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10686
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Blaze Bioscience Inc (Blaze) is a biotechnology company that offers guided cancer therapy solutions. The company develops tumor paint products and optide-based guided cancer therapeutics. It provides cancer surgery by development of real-time, high-resolution view of cancer cell technologies. Blaze’s pipeline products include BLZ-100, a tumor paint product candidate for cancer surgery in multiple solid tumor types. The company provides products which are used for the treatment of brain cancer, breast cancer, prostate cancer, lung cancer, colorectal cancer, skin cancer, and other solid tumor cancers. Its BLZ-100 consists of an optide that binds and internalizes into cancer cells. Blaze is headquartered in Seattle, Washington, the US.

Blaze Bioscience Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Blaze Bioscience Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Blaze Bioscience Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Blaze Bioscience Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Blaze Bioscience Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Blaze Bioscience Inc, Medical Devices Deals, 2012 to YTD 2018 9
Blaze Bioscience Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Blaze Bioscience Inc, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Blaze Bioscience Raises USD3 Million in Venture Financing 11
Blaze Bioscience Raises USD16 Million in Venture Financing 12
Blaze Bioscience Raises USD0.6 Million in Venture Financing 13
Blaze Bioscience to Raise Additional USD5.3 Million in Series B Financing 14
Blaze Bioscience Raises US$9 Million In Series B Financing 15
Blaze Bioscience Raises US$8.5 Million In Series A Financing 16
Blaze Bioscience Raises US$6.4 Million In Venture Financing 17
Partnerships 18
Denali Therapeutics Enters into Research Agreement with Blaze Bioscience 18
Blaze Bioscience Enters Into Agreement With Fred Hutchinson Cancer Research Center For Optides Discovery Program 19
Licensing Agreements 20
Blaze Bioscience Enters into Licensing Agreement with Morphotek 20
Blaze Bioscience Inc – Key Competitors 21
Blaze Bioscience Inc – Key Employees 22
Blaze Bioscience Inc – Locations And Subsidiaries 23
Head Office 23
Recent Developments 24
Product News 24
Mar 28, 2017: Blaze Bioscience Announces Tumor Paint BLZ-100 Publication in International Journal of Toxicology 24
Appendix 25
Methodology 25
About GlobalData 25
Contact Us 25
Disclaimer 25

List of Tables
Blaze Bioscience Inc, Pharmaceuticals & Healthcare, Key Facts 2
Blaze Bioscience Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Blaze Bioscience Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Blaze Bioscience Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Blaze Bioscience Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Blaze Bioscience Inc, Medical Devices Deals, 2012 to YTD 2018 9
Blaze Bioscience Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Blaze Bioscience Raises USD3 Million in Venture Financing 11
Blaze Bioscience Raises USD16 Million in Venture Financing 12
Blaze Bioscience Raises USD0.6 Million in Venture Financing 13
Blaze Bioscience to Raise Additional USD5.3 Million in Series B Financing 14
Blaze Bioscience Raises US$9 Million In Series B Financing 15
Blaze Bioscience Raises US$8.5 Million In Series A Financing 16
Blaze Bioscience Raises US$6.4 Million In Venture Financing 17
Denali Therapeutics Enters into Research Agreement with Blaze Bioscience 18
Blaze Bioscience Enters Into Agreement With Fred Hutchinson Cancer Research Center For Optides Discovery Program 19
Blaze Bioscience Enters into Licensing Agreement with Morphotek 20
Blaze Bioscience Inc, Key Competitors 21
Blaze Bioscience Inc, Key Employees 22

List of Figures
Blaze Bioscience Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Blaze Bioscience Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Blaze Bioscience Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Blaze Bioscience Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Blaze Bioscience Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Blaze Bioscience Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Blaze Bioscience Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Blaze Bioscience Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Blaze Bioscience Inc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Blaze Bioscience Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Pilgrim’s Pride Corporation:企業の戦略・SWOT・財務情報
    Pilgrim's Pride Corporation - Strategy, SWOT and Corporate Finance Report Summary Pilgrim's Pride Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • SYNNEX Corporation:企業の戦略・SWOT・財務情報
    SYNNEX Corporation - Strategy, SWOT and Corporate Finance Report Summary SYNNEX Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Continental Resources Inc (CLR):企業の財務・戦略的SWOT分析
    Summary Continental Resources Inc (Continental Resources) is an independent upstream oil and gas company. The company explores for, develops and produces crude oil and natural gas. It operates in the onshore oil field, the Bakken of North Dakota and Montana; SCOOP play in Woodford reservoir; SCOOP S …
  • Orkla ASA:企業のM&A・事業提携・投資動向
    Orkla ASA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Orkla ASA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capita …
  • IndusInd Bank Ltd:企業のM&A・事業提携・投資動向
    IndusInd Bank Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's IndusInd Bank Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), div …
  • AGL Energy Ltd (AGL):電力:M&Aディール及び事業提携情報
    Summary AGL Energy Limited (AGL) is an integrated energy company that owns, operates and develops energy assets and provides natural gas, electricity, solar photovoltaic solutions and related products and services. The company’s power generation portfolio includes coal, gas, hydro, wind, solar, land …
  • Avedro Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Avedro Inc (Averdro) is a medical device company that manufactures and distributes cross-linking systems and riboflavin ophthalmic products. The company’s products include mosaic systems for PiXL, lasik xtra, and accelerated cross-linking; KXL systems for lasik xtra and accelerated cross-lin …
  • Grant Thornton International Ltd:企業の戦略的SWOT分析
    Grant Thornton International Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • Mitsui & Co., Ltd.:企業の戦略・SWOT・財務分析
    Mitsui & Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Mitsui & Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • FOX Broadcasting Co:企業の戦略的SWOT分析
    FOX Broadcasting Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Reliance Life Sciences Pvt Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Reliance Life Sciences Pvt Ltd (Reliance Life Sciences) a subsidiary of Reliance Industries Limited, is a biotechnology company which manufactures and develops medical products for healthcare industry. The company’s product portfolio includes plasma proteins, biosimilars, proteins, steroid, …
  • Convergys Corporation:企業の戦略・SWOT・財務情報
    Convergys Corporation - Strategy, SWOT and Corporate Finance Report Summary Convergys Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Jefferies Group LLC:企業の戦略・SWOT・財務情報
    Jefferies Group LLC - Strategy, SWOT and Corporate Finance Report Summary Jefferies Group LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Humabs BioMed SA-製薬・医療分野:企業M&A・提携分析
    Summary Humabs BioMed SA (Humabs) is an antibody therapeutics biotechnology company that discovers and develops human monoclonal antibodies. The company’s pipeline programs include Flu A virus, ebola virus, HBV, rabies virus, JCV, dengue, and others. It develops cellclone technologies, a proprietary …
  • Hermes Europe GmbH:企業の戦略的SWOT分析
    Hermes Europe GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • TTM Technologies, Inc.:企業の戦略・SWOT・財務情報
    TTM Technologies, Inc. - Strategy, SWOT and Corporate Finance Report Summary TTM Technologies, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • ImpediMed Ltd (IPD):企業の財務・戦略的SWOT分析
    ImpediMed Ltd (IPD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Idemitsu Kosan Co., Ltd.:企業の戦略・SWOT・財務情報
    Idemitsu Kosan Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Idemitsu Kosan Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • TECT Aerospace, Inc.:企業の戦略・SWOT・財務分析
    TECT Aerospace, Inc. - Strategy, SWOT and Corporate Finance Report Summary TECT Aerospace, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Solo Oil plc (SOLO):企業の財務・戦略的SWOT分析
    Summary Solo Oil Plc (Solo Oil), formerly Immersion Technologies International Plc, is an oil and gas exploration and production company that acquires, explores, develops and produces oil and gas resource development and production assets. The company's non operated oil and gas assets portfolio incl …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆